Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | sphingosine-1-phosphate lyase 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Pyridoxal-dependent decarboxylase conserved domain containing protein | sphingosine-1-phosphate lyase 1 | 568 aa | 524 aa | 39.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0166 | 0.0108 | 0.0108 |
Echinococcus multilocularis | cathepsin b | 0.1313 | 0.2975 | 1 |
Brugia malayi | Pepsin A precursor | 0.0166 | 0.0108 | 0.0364 |
Leishmania major | cysteine peptidase C (CPC),CPC cysteine peptidase, Clan CA, family C1, Cathepsin B-like | 0.0433 | 0.0777 | 1 |
Plasmodium falciparum | plasmepsin VII | 0.0166 | 0.0108 | 0.5 |
Brugia malayi | aspartic protease BmAsp-1, identical | 0.0166 | 0.0108 | 0.0364 |
Plasmodium vivax | plasmepsin IV, putative | 0.0166 | 0.0108 | 0.5 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0166 | 0.0108 | 0.0108 |
Loa Loa (eye worm) | cathepsin B | 0.0433 | 0.0777 | 0.2612 |
Loa Loa (eye worm) | aspartic protease BmAsp-2 | 0.0166 | 0.0108 | 0.0364 |
Plasmodium falciparum | plasmepsin VIII, putative | 0.0166 | 0.0108 | 0.5 |
Toxoplasma gondii | cathepsin B | 0.0433 | 0.0777 | 1 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0166 | 0.0108 | 0.0108 |
Loa Loa (eye worm) | hypothetical protein | 0.0166 | 0.0108 | 0.0364 |
Loa Loa (eye worm) | hypothetical protein | 0.0166 | 0.0108 | 0.0364 |
Echinococcus multilocularis | cathepsin b | 0.1313 | 0.2975 | 1 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0166 | 0.0108 | 0.0108 |
Plasmodium falciparum | plasmepsin I | 0.0166 | 0.0108 | 0.5 |
Plasmodium vivax | plasmepsin V, putative | 0.0166 | 0.0108 | 0.5 |
Brugia malayi | hypothetical protein | 0.0166 | 0.0108 | 0.0364 |
Entamoeba histolytica | s phingosine-1-phosphate lyase 1, putative | 0.0122 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0166 | 0.0108 | 0.0364 |
Plasmodium falciparum | plasmepsin IV | 0.0166 | 0.0108 | 0.5 |
Echinococcus granulosus | cathepsin d lysosomal aspartyl protease | 0.0166 | 0.0108 | 0.0364 |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.0433 | 0.0777 | 0.2612 |
Loa Loa (eye worm) | aspartyl protease 6 | 0.0166 | 0.0108 | 0.0364 |
Giardia lamblia | Cathepsin B precursor | 0.0433 | 0.0777 | 0.5 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0166 | 0.0108 | 0.5 |
Plasmodium falciparum | plasmepsin VI | 0.0166 | 0.0108 | 0.5 |
Brugia malayi | Eukaryotic aspartyl protease family protein | 0.0166 | 0.0108 | 0.0364 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0166 | 0.0108 | 0.0108 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0433 | 0.0777 | 1 |
Brugia malayi | hypothetical protein | 0.0166 | 0.0108 | 0.0364 |
Plasmodium falciparum | plasmepsin III | 0.0166 | 0.0108 | 0.5 |
Plasmodium falciparum | plasmepsin X | 0.0166 | 0.0108 | 0.5 |
Brugia malayi | aspartic protease BmAsp-2, identical | 0.0166 | 0.0108 | 0.0364 |
Plasmodium vivax | aspartyl protease, putative | 0.0166 | 0.0108 | 0.5 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0433 | 0.0777 | 0.0777 |
Plasmodium falciparum | plasmepsin II | 0.0166 | 0.0108 | 0.5 |
Plasmodium falciparum | plasmepsin V | 0.0166 | 0.0108 | 0.5 |
Trypanosoma brucei | cysteine peptidase C (CPC) | 0.0433 | 0.0777 | 1 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0166 | 0.0108 | 0.0108 |
Echinococcus multilocularis | cathepsin d (lysosomal aspartyl protease) | 0.0166 | 0.0108 | 0.0364 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0166 | 0.0108 | 0.0108 |
Onchocerca volvulus | 0.0166 | 0.0108 | 0.5 | |
Onchocerca volvulus | 0.0166 | 0.0108 | 0.5 | |
Echinococcus granulosus | cathepsin b | 0.1313 | 0.2975 | 1 |
Giardia lamblia | Cathepsin B precursor | 0.0433 | 0.0777 | 0.5 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0166 | 0.0108 | 0.0108 |
Loa Loa (eye worm) | aspartic protease BmAsp-1 | 0.0166 | 0.0108 | 0.0364 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0166 | 0.0108 | 0.5 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.1313 | 0.2975 | 0.2975 |
Plasmodium vivax | aspartyl protease, putative | 0.0166 | 0.0108 | 0.5 |
Echinococcus granulosus | cathepsin b | 0.1313 | 0.2975 | 1 |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.1313 | 0.2975 | 1 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0166 | 0.0108 | 0.0108 |
Loa Loa (eye worm) | hypothetical protein | 0.1313 | 0.2975 | 1 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.1313 | 0.2975 | 0.2975 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.1313 | 0.2975 | 0.2975 |
Brugia malayi | cathepsin B-like cysteine proteinase | 0.1313 | 0.2975 | 1 |
Plasmodium vivax | aspartyl protease, putative | 0.0166 | 0.0108 | 0.5 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0166 | 0.0108 | 0.0108 |
Plasmodium falciparum | plasmepsin IX | 0.0166 | 0.0108 | 0.5 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0166 | 0.0108 | 0.0108 |
Giardia lamblia | Cathepsin B precursor | 0.0433 | 0.0777 | 0.5 |
Schistosoma mansoni | SmCB2 peptidase (C01 family) | 0.1313 | 0.2975 | 0.2975 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 2.5 uM | Inhibition of human recombinant S1PL (62 to 568) expressed in Sf9 insect cells using S1P as substrate after 1 hr | ChEMBL. | 24809814 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.